Showing 1 - 8 results of 8 for search 'Rikako Tabata', query time: 0.03s Refine Results
  1. 1
    Emerging Immunotherapy for Acute Myeloid Leukemia

    Emerging Immunotherapy for Acute Myeloid Leukemia by Rikako Tabata, SungGi Chi, Junichiro Yuda, Yosuke Minami

    Published 2021-02-01
    Get full text
    Article
  2. 2
    Brain toxoplasmosis after HLA haploidentical transplantation for acute myeloid leukemia

    Brain toxoplasmosis after HLA haploidentical transplantation for acute myeloid leukemia by Takafumi Tsushima, Rikako Tabata, Kentaro Narita, Koichi Honma, Kengo Takeuchi, Kosei Matsue

    Published 2022-08-01
    Get full text
    Article
  3. 3
    Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria

    Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria by Kentaro Narita, Daisuke Miura, Takafumi Tsushima, Toshiki Terao, Ayumi Kuzume, Rikako Tabata, Masami Takeuchi, Kosei Matsue

    Published 2021-07-01
    Get full text
    Article
  4. 4
    P1547: CLINICAL CHARACTERISTICS OF PATIENTS WITH PROLONGED VIRAL SHEDDING OF OMICRON VARIANT IN HAEMATOLOGICAL DISEASE

    P1547: CLINICAL CHARACTERISTICS OF PATIENTS WITH PROLONGED VIRAL SHEDDING OF OMICRON VARIANT IN HAEMATOLOGICAL DISEASE by Daisuke Ikeda, Kentaro Narita, Ami Fukumoto, Yuka Uesugi, Rikako Tabata, Daisuke Miura, Masami Takeuchi, Kosei Matsue

    Published 2023-08-01
    Get full text
    Article
  5. 5
    P1137: COMBINED METABOLIC HETEROGENEITY AND TOTAL LESION GLYCOLYSIS FROM PET-CT IMPROVES THE PROGNOSTIC STRATIFICATION IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA

    P1137: COMBINED METABOLIC HETEROGENEITY AND TOTAL LESION GLYCOLYSIS FROM PET-CT IMPROVES THE PROGNOSTIC STRATIFICATION IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA by Daisuke Ikeda, Ami Fukumoto, Yuka Uesugi, Rikako Tabata, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Yoichi Machida, Kosei Matsue

    Published 2023-08-01
    Get full text
    Article
  6. 6
    Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease

    Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease by Daisuke Ikeda, Ami Fukumoto, Yuka Uesugi, Rikako Tabata, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Tomohisa Watari, Yoshihito Otsuka, Kosei Matsue

    Published 2023-09-01
    Get full text
    Article
  7. 7
    Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study

    Prevalence and Clinical Outcome of Omicron Breakthrough Infection in Patients With Hematologic Disease: A Prospective Observational Cohort Study by Kentaro Narita, Daisuke Ikeda, Mizuki Seki, Ami Fukumoto, Rikako Tabata, Yuka Uesugi, Daisuke Miura, Masami Takeuchi, Masahiro Doi, Yuka Umezawa, Yoshihito Otsuka, Kosei Matsue

    Published 2023-06-01
    Get full text
    Article
  8. 8
    Impaired Antibody Response Following the Second Dose of the BNT162b2 Vaccine in Patients With Myeloproliferative Neoplasms Receiving Ruxolitinib

    Impaired Antibody Response Following the Second Dose of the BNT162b2 Vaccine in Patients With Myeloproliferative Neoplasms Receiving Ruxolitinib by Daisuke Ikeda, Toshiki Terao, Daisuke Miura, Kentaro Narita, Ami Fukumoto, Ayumi Kuzume, Yuya Kamura, Rikako Tabata, Takafumi Tsushima, Masami Takeuchi, Takaaki Hosoki, Kosei Matsue

    Published 2022-03-01
    Get full text
    Article

Search Tools: